1002 (1002) Fair Value & Analysis

Basic Materials · Market cap HK$146M

1 1002 1002 · HK

PriceHK$0.0580

Fair ValueHK$0.0418

Upside-28.0%

Quality52/100

Evidence: Medium Range HK$0.0360 – HK$0.0476

Fair value as of: Jul 2, 2026

From 26 valuation models · updated today

Share price −10.8% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.0480 – HK$0.0810 · fair‑value band HK$0.0360 – HK$0.0476 · the HK$0.0580 price screens above the HK$0.0418 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1002 (1002) currently trades at HK$0.0580, while our model-based Fair Value estimate is HK$0.0418 — implying the stock looks roughly 28.0% overvalued today. We read business quality at 52/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

Over the trailing twelve months, 1002 generated revenue of HK$64.1M at a net margin of 0.6%. It earns a return on equity of 3.0%. The balance sheet holds a net cash position of HK$31.4M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$64.1M

Revenue growth (YoY) +28,417%

Net margin 0.6%

Return on equity 3.0%

Free cash flow HK$56.3M FY2025

Operating margin 11.7%

More key figures

Net cash HK$31.4M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1002 reported revenue of HK$448M in FY2025 versus HK$256M in FY2021, a compound +15.0%/yr. Reported net income was HK$2.8M in FY2025.

Revenue +15.0%/yr

FY21 HK$256M

FY22 HK$121M

FY23 HK$76.4M

FY24 HK$56.0M

FY25 HK$448M

Net income

FY21 −HK$5.6M

FY22 −HK$48.2M

FY23 −HK$22.3M

FY24 −HK$9.5M

FY25 HK$2.8M

Is 1002 fairly valued? → Check now

Similar stocks

6 more Specialty Chemicals stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
Linde plc LIN	$516.71	$221.55	-57%
L'Air Liquide S.A AIQUY	$37.81	$15.56	-59%
Air Products and Chemicals, Inc A1PD34	R$360.05	R$174.71	-51%
Intercontinental Exchange, Inc I1CE34	R$359.64	R$307.76	-14%
Wanhua Chemical Group 600309	¥67.90	¥46.52	-31%
Asian Paints Limited ASIANPAINT	₹2,674	₹739.38	-72%

Explore undervalued stocks

More undervalued Basic Materials stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1002 (1002) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.0418 versus a price of HK$0.0580 — about −28% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1002?

Our model-based fair value for 1002 is HK$0.0418 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.0580.

What is the quality score of 1002?

1002 has a Quality Score of 52/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1002 (1002)?

1002 reported trailing-twelve-month revenue of about HK$64.1M (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1002?

The net profit margin of 1002 is about 0.6%, meaning it keeps roughly 0.6% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.